Tissue-specific target analysis of disease-associated microRNAs in human signaling pathways

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Kowarsch, Andreas ^a   Marr, Carsten ^a   Schmidl, Daniel ^a,b   Ruepp, Andreas ^a   Theis, Fabian J ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CELL NUCLEUS; CELLS AND CELL COMPONENTS; CELLULAR DISTRIBUTION; GENE CONTROL; GENE INTERACTION; GENE LOCATION; GENE TARGETING; HUMAN; SIGNAL TRANSDUCTION; GENERAL ASPECTS OF DISEASE; GENETICS;

DISEASE; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 77956224305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011154     Document Type: Article

References (57)

1. Kloosterman WP, Plasterk RHA (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
2. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.
3. Chi SW, Zang JB, Mele A, Darnell RB (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
4. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609.
5. Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
6. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, et al. (2009) Modulation of microRNA processing by p53. Nature 460: 529-533.
7. Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A, et al. (2008) MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat Neurosci.
8. Kennell JA, Gerin I, MacDougald OA, Cadigan KM (2008) The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A 105: 15417-15422.
9. Ricarte-Filho JCM, Fuziwara CS, Yamashita AS, Rezende E, Da-Silva MJ, et al. (2009) Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer. Translational oncology 2: 236-41.
10. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
11. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
12. Couzin J (2008) MicroRNAs make big impression in disease after disease. Science 319: 1782-1784.
13. Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
14. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109-11.
15. Ruepp A, Kowarsch A, Schmidl D, Bruggenthin F, Brauner B, et al. (2010) PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome biology 11: R6.
16. Hausser J, Landthaler M, Jaskiewicz L, Gaidatzis D, Zavolan M (2009) Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets. Genome research 19: 2009-20.
17. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 101: 6062-7.
18. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, et al. (2008) PID: the Pathway Interaction Database. Nucleic Acids Res.
19. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: 480-484.
20. Hamosh A, Scott AF, Amberger JS, Bocchini CA, Mckusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33, Database issue, D514-D517.
21. Shimodaira H (2002) An approximately unbiased test of phylogenetic tree selection. Systematic biology 51: 492-508.
22. Wu E, Palmer N, Tian Z, Moseman AP, Galdzicki M, et al. (2008) Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. PLoS ONE 3: e3794.
23. Heldin CH, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, et al. (1986) A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511-514.
24. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, et al. (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2: 302-309.
25. Ross R, Glomset J, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71: 1207-1210.
26. George D (2003) Targeting PDGF receptors in cancer-rationales and proof of concept clinical trials. Advances in experimental medicine and biology 532: 141-51.
27. Perrone G, Vincenzi B, Zagami M, Santini D, Panteri R, et al. (2007) Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 20: 344-51.
28. Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F (2007) Human embryonic and neuronal stem cell markers in retinoblastoma. Molecular vision 13: 823-32.
29. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, et al. (2002) Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 22: 3389-3403.
30. Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, et al. (2009) MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 23: 4276-87.
31. McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23.
32. Irminger-Finger I, Jefford CE (2006) Is there more to BARD1 than BRCA1? Nature reviews Cancer 6: 382-91.
33. Bruning JC, Gillette JA, Zhao Y, Bjorbaeck C, Kotzka J, et al. (2000) Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc Natl Acad Sci U S A 97: 2462-2467.
34. Okazaki K, Sagata N (1995) The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J 14: 5048-5059.
35. Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, et al. (2005) Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 25: 6964-6979.
36. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
37. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
38. Chiao PJ, Na R, Niu J, Sclabas GM, Dong Q, et al. (2002) Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 95: 1696-1705.
39. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R (1999) Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene 18: 6888-6895.
40. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nature genetics 37: 495-500.
41. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human microRNA targets. PLoS Biol 2 e363.
42. TargetSpy (2009) URL http://webclu.bio.wzw.tum.de/targetspy/.
43. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
44. Sethupathy P, Megraw M, Hatzigeorgiou AG (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886.
45. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, et al. (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21: 577-581.
46. Friedman RC, Farh KKH, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
47. Xu J, Wong C (2008) A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA 14: 1276-1283.
48. Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-87.
49. Lutter D, Marr C, Krumsiek J, Lang E, Theis F (2010) Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. BMC genomics 11: 224.
50. Cui Q, Yu Z, Purisima EO, Wang E (2006) Principles of microRNA regulation of a human cellular signaling network. Molecular Systems Biology 1-7.
51. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23: 1147-1157.
52. Yeilding NM, Rehman MT, Lee WM (1996) Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol Cell Biol 16: 3511-3522.
53. Kabnick KS, Housman DE (1988) Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA. Mol Cell Biol 8: 3244-3250.
54. Hollams EM, Giles KM, Thomson AM, Leedman PJ (2002) MRNA stability and the control of gene expression: implications for human disease. Neurochem Res 27: 957-980.
55. Legewie S, Herzel H, Westerhoff HV, Blüthgen N (2008) Recurrent design patterns in the feedback regulation of the mammalian signalling network. Molecular Systems Biology 1-7.
56. Klamt S, Haus UU, Theis F (2009) Hypergraphs and cellular networks. PLoS Comput Biol 5: e1000385.
57. McClintick JN, Edenberg HJ (2006) Effects of filtering by Present call on analysis of microarray experiments. BMC bioinformatics 7: 49.